Douglas E Vaughan

Title: Douglas E Vaughan: Innovator in Therapeutic Methods

Introduction

Douglas E Vaughan is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of therapeutic methods, particularly in the area of PAI-1 inhibitors. With a total of 2 patents, Vaughan's work has the potential to impact medical treatments and research.

Latest Patents

Vaughan's latest patents include innovative methods that employ PAI-1 inhibitors. One patent details a method for testing candidate compositions for PAI-1 inhibition activity. This method involves obtaining a transgenic non-human warm-blooded vertebrate animal with a PAI-1 gene incorporated into its genome. The process includes administering the candidate composition to the animal and observing changes indicative of PAI-1 activity inhibition. Another patent focuses on angiotensin IV and its analogs as regulators of fibrinolysis. This research reveals that angiotensin IV interacts with endothelial cells to induce PAI-1 expression, thereby inhibiting clot lysis. The findings suggest that fibrinolysis can be promoted by reducing angiotensin IV levels.

Career Highlights

Throughout his career, Vaughan has worked with esteemed institutions such as Brigham and Women's Hospital and Vanderbilt University. His research has contributed to advancements in understanding the mechanisms of fibrinolysis and the role of PAI-1 in various physiological processes.

Collaborations

Vaughan has collaborated with notable professionals in his field, including Mesut Eren and Paul Declerck. These partnerships have further enriched his research and innovation efforts.

Conclusion

Douglas E Vaughan's contributions to therapeutic methods and his innovative patents highlight his role as a key figure in medical research. His work continues to pave the way for advancements in treatment methodologies.